Search the Site

Twitter

test tubes

 

Some of the features of BioRunUp.com include:

- Detailed Reports on Upcoming FDA and Clinical Trial Trades
- REAL TIME Posting of Trades (Entries and Exits)
- Clinical and Regualtory Catalyst Database with over 400 events and updated daily
- Members Only Live Interactive Webinars
- Live Chat Room
- Video Lessons / Trade Reviews
- Chart / Technical Analysis
- Run-Up Valuation Studies
- Weekly Video Watchlist
- SMS Alerts of breaking biotech news
- Access to Mark Messier and Mike Havrilla's Trading Accounts 
- Watch FOUR Profitable Biotech Traders in Real Time
- A More Detailed FDA Calendar
- Historical FDA Tracker
- Bio-Pharma, FDA, Clinical Trials, and Stock Market News Updates
- Direct Email Communication
- Affiliate Program

Join Our FREE Mailing List and Receive the eBook
"Five Tips to Better Biotech Trading / 
Understanding the BioCatalyst Process"

The cost for an annual subscription is $697 and includes all the above features. We also offer a monthly plan for $99.95

CLICK HERE TO JOIN BIORUNUP

Take a look at excerpts from BioRunUp subscriber testimonials:

"My most recent and profitable trade are the EXAS Oct $5 options which I purchased at $.40 off of BioRunUp blog alert. They are currently yielding a 700% return!!!"

"Within 1 month my brand new porfolio was up over 23%!"

"In the first month I made a 13% return, doubling the return of the market as a whole - without leverage. To date, I have never failed to beat the market when applying the methods outlined in the pages of BioRunUp."

"I don’t ever take recommendations from people on the Internet, but this one looked right, felt right and sounded right. Thanks BioRunUp, you made me a fortune."


To read more testimonials, click HERE

 

Recent verified trading profits of over $1,000,000

Mark Messier

Mike Havrilla

 

Recent articles

 

BioRunUp Webinar - Thursday 4/24/14 4:30pm EST

(in: Articles)
 

$SPPI Spectrum Pharma Poised For Run-Up Into PDUFA Catalyst

(in: Articles)
 

$ONTX Onconova Trading Near Cash After Phase 3 Setback & Biotech Sell-Off

(in: Articles)
 

$ACST Acasti Poised For Oversold Bounce Ahead Of Phase 2 Results

(in: Articles)
 

$EGRX Eagle Pharma Poised For Run-Up Into Pair Of July PDUFA Catalysts

(in: Articles)
 

This Week's Watchlist 4/21/14

(in: Articles)
 

$NAVB Navidea: Multiple Clinical & Regulatory Catalysts for Lymphoseek in 2014

(in: Articles)
 

Steve's Comments on Current Positions

(in: Articles)
 

4/14/14 Catalyst Summary

(in: Articles)
 

$STXS Stereotaxis: Medical Robotics Specialist With FDA 510(k) Catalyst

(in: Articles)
 

This Week's Watchlist 4/14/14

(in: Articles)
 

$XBI $IBB $BIS Bio Run-Down Trading: Shorting The Rips & Covering The Dips

(in: Articles)
 

$KMDA Kamada: Near-Term Pivotal Study Catalyst For Rare Lung Disease

(in: Articles)
 

$OREX Orexigen: US & EU Regulatory Approval Decisions Expected In 2014

(in: Articles)
 

$PGNX Progenics Awaits New FDA Ad-Com For Relistor

(in: Articles)
 

$HALO Halozyme Hits Turbulence After An Extended Run-Up

(in: Articles)
 

$BDSI BioDelivery Sciences Poised For Run-Up Into Bunavail Catalysts

(in: Articles)
 

$SGYP Synergy Pharma Poised For Success In Phase 2 & 3 Trials

(in: Articles)
 

4/7/14 Catalyst Summary

(in: Articles)
 

$GNCA Genocea: Vaccine Developer With A Pair Of Clinical Catalysts

(in: Articles)